Benzinga | Sep 27, 2021 08:06AM EDT

Evofem Biosciences Highlights Publication On 'the variability of contraceptive clinical trial design and its impact on efficacy outcomes' In Peer-Reviewed Journal Advances In Therapy

Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that a manuscript on the variability of contraceptive clinical trial design and its impact on efficacy outcomes has been published in the peer-reviewed journal Advances in Therapy.